The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer{A figure is presented}

Georg C. Hutterer, Alberto Briganti, F. K H Chun, Andrea Gallina, Patrizio Rigatti, Francesco Montorsi, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: We performed a systematic literature review of the staging of pelvic lymph node metastases in clinically localized prostate cancer. Methods: The description of the evolution of the staging paradigms of lymph node invasion (LNI) in localized prostate cancer is based on a systematic review of the English language literature on this topic. Results: A single randomized trial addressing pelvic lymph node dissection (PLND) exists and no Cochrane review covers the topic of lymph node staging in localized prostate cancer. Most publications are based on retrospective analyses, including some large multicenter validation studies. The available reports demonstrate that extended PLND improves staging and that ideally 30 lymph nodes should be removed. This represents a shift away from either no PLND or very limited PLND, in historic series. However, not all men need to be subjected to an extended PLND. At least some patients can be effectively staged with limited PLND. Conclusions: This review illustrates the evolution of lymph node staging in prostate cancer, which changed from no staging through limited staging to extended staging. This review provides evidence-based criteria for identifying patients at risk of LNI, as well as for defining the extent of PLND, when indicated.

Original languageEnglish
Pages (from-to)153-162
Number of pages10
JournalEAU-EBU Update Series
Volume5
Issue number4
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Lymph Node Excision
Prostatic Neoplasms
Lymph Nodes
Neoplasm Metastasis
Validation Studies
Multicenter Studies
Publications
Language

Keywords

  • Complications
  • Lymph node invasion
  • Pelvic lymphadenectomy
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer{A figure is presented}. / Hutterer, Georg C.; Briganti, Alberto; Chun, F. K H; Gallina, Andrea; Rigatti, Patrizio; Montorsi, Francesco; Karakiewicz, Pierre I.

In: EAU-EBU Update Series, Vol. 5, No. 4, 08.2007, p. 153-162.

Research output: Contribution to journalArticle

Hutterer, Georg C. ; Briganti, Alberto ; Chun, F. K H ; Gallina, Andrea ; Rigatti, Patrizio ; Montorsi, Francesco ; Karakiewicz, Pierre I. / The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer{A figure is presented}. In: EAU-EBU Update Series. 2007 ; Vol. 5, No. 4. pp. 153-162.
@article{be58db360d0b4d92883bddb18cf4c16b,
title = "The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer{A figure is presented}",
abstract = "Objectives: We performed a systematic literature review of the staging of pelvic lymph node metastases in clinically localized prostate cancer. Methods: The description of the evolution of the staging paradigms of lymph node invasion (LNI) in localized prostate cancer is based on a systematic review of the English language literature on this topic. Results: A single randomized trial addressing pelvic lymph node dissection (PLND) exists and no Cochrane review covers the topic of lymph node staging in localized prostate cancer. Most publications are based on retrospective analyses, including some large multicenter validation studies. The available reports demonstrate that extended PLND improves staging and that ideally 30 lymph nodes should be removed. This represents a shift away from either no PLND or very limited PLND, in historic series. However, not all men need to be subjected to an extended PLND. At least some patients can be effectively staged with limited PLND. Conclusions: This review illustrates the evolution of lymph node staging in prostate cancer, which changed from no staging through limited staging to extended staging. This review provides evidence-based criteria for identifying patients at risk of LNI, as well as for defining the extent of PLND, when indicated.",
keywords = "Complications, Lymph node invasion, Pelvic lymphadenectomy, Prostate cancer, Radical prostatectomy",
author = "Hutterer, {Georg C.} and Alberto Briganti and Chun, {F. K H} and Andrea Gallina and Patrizio Rigatti and Francesco Montorsi and Karakiewicz, {Pierre I.}",
year = "2007",
month = "8",
doi = "10.1016/j.eeus.2007.04.003",
language = "English",
volume = "5",
pages = "153--162",
journal = "EAU-EBU Update Series",
issn = "1871-2592",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer{A figure is presented}

AU - Hutterer, Georg C.

AU - Briganti, Alberto

AU - Chun, F. K H

AU - Gallina, Andrea

AU - Rigatti, Patrizio

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I.

PY - 2007/8

Y1 - 2007/8

N2 - Objectives: We performed a systematic literature review of the staging of pelvic lymph node metastases in clinically localized prostate cancer. Methods: The description of the evolution of the staging paradigms of lymph node invasion (LNI) in localized prostate cancer is based on a systematic review of the English language literature on this topic. Results: A single randomized trial addressing pelvic lymph node dissection (PLND) exists and no Cochrane review covers the topic of lymph node staging in localized prostate cancer. Most publications are based on retrospective analyses, including some large multicenter validation studies. The available reports demonstrate that extended PLND improves staging and that ideally 30 lymph nodes should be removed. This represents a shift away from either no PLND or very limited PLND, in historic series. However, not all men need to be subjected to an extended PLND. At least some patients can be effectively staged with limited PLND. Conclusions: This review illustrates the evolution of lymph node staging in prostate cancer, which changed from no staging through limited staging to extended staging. This review provides evidence-based criteria for identifying patients at risk of LNI, as well as for defining the extent of PLND, when indicated.

AB - Objectives: We performed a systematic literature review of the staging of pelvic lymph node metastases in clinically localized prostate cancer. Methods: The description of the evolution of the staging paradigms of lymph node invasion (LNI) in localized prostate cancer is based on a systematic review of the English language literature on this topic. Results: A single randomized trial addressing pelvic lymph node dissection (PLND) exists and no Cochrane review covers the topic of lymph node staging in localized prostate cancer. Most publications are based on retrospective analyses, including some large multicenter validation studies. The available reports demonstrate that extended PLND improves staging and that ideally 30 lymph nodes should be removed. This represents a shift away from either no PLND or very limited PLND, in historic series. However, not all men need to be subjected to an extended PLND. At least some patients can be effectively staged with limited PLND. Conclusions: This review illustrates the evolution of lymph node staging in prostate cancer, which changed from no staging through limited staging to extended staging. This review provides evidence-based criteria for identifying patients at risk of LNI, as well as for defining the extent of PLND, when indicated.

KW - Complications

KW - Lymph node invasion

KW - Pelvic lymphadenectomy

KW - Prostate cancer

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=34250630581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250630581&partnerID=8YFLogxK

U2 - 10.1016/j.eeus.2007.04.003

DO - 10.1016/j.eeus.2007.04.003

M3 - Article

AN - SCOPUS:34250630581

VL - 5

SP - 153

EP - 162

JO - EAU-EBU Update Series

JF - EAU-EBU Update Series

SN - 1871-2592

IS - 4

ER -